Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Gepotidacin mesylate by GSK for Uncomplicated Cervical And Urethral Gonorrhea: Likelihood of Approval
Gepotidacin mesylate is under clinical development by GSK and currently in Phase III for Uncomplicated Cervical And Urethral Gonorrhea. According...